Insider trade

Officer sold ~$1.47M of CL shares in the open market

Traded Feb 12, 2026 · Filed Feb 13, 2026

~$1.47M
Reported value · 15K sh @ $97.8074: 10K
Holds after · shares reported: -12.1%
stock since the trade · S&P 500 +12.1%, $96.17 → $84.53 on Oct 1

Why it stands out

Colgate-Palmolive's COO, Eur., APac, Afr Eur, Skin sold $1.47M of Colgate-Palmolive shares. It happened by itself, for taxes or pay.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Feb 12, 2026
Reporting period: Not applicable
Filed with the SEC: Feb 13, 2026

Officer$1M+Pre-arranged plan referenced

Context

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$1,467,111

Shares × reported transaction price

Timing vs results

13 days after results of Jan 30, 2026, 78 days before results of May 1, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Price at the time

Closed at $96.17 on Feb 12, 2026, within 2% of its 52-week high, after a 21% rise over the previous 30 trading days

52-week range $74.98 (Nov 3, 2025) to $97.50 (Mar 10, 2025), 94% of the way up, from 251 adjusted closes. 30 trading days earlier: $79.51 on Dec 30, 2025. Describes the past only, not a forecast

Planned / mechanical clue

Footnote references tax withholding

Only flagged when a footnote says so; never inferred

After it was reported

After	Stock	S&P 500	Difference
7 days	+2.6%	+0.7%	+1.9%
30 days	-10.6%	-3.4%	-7.2%
90 days	-6.0%	+8.2%	-14.2%
180 days	-5.7%	+13.2%	-18.8%

Past results only. Not a forecast.

Source receipt

Record ID: 0001225208-26-001844
Filed / recorded: Feb 13, 2026, 9:25 PM UTC
Added to OQRO: Oct 2, 2026, 12:27 PM UTC
Parser: form4-xml-v1
Data quality: Verified: identifiers matched exactly
Issuer: COLGATE PALMOLIVE CO
Issuer CIK: 21665
Ticker: CL
Reporting person: Panagiotis Tsourapas
Relationship: Officer
Officer title: COO, Eur., APac, Afr Eur, Skin
Security: Common Stock
Table: Non-derivative (Table I)
Transaction date: Feb 12, 2026
Transaction code: S
Shares / units: 15,000
Price per share: $97.8074
Acquired / disposed: Disposed (D)
Shares owned after: 10,415
Ownership form: Direct
Amendment: No

Footnotes from the filing

Sale of shares with a portion of the proceeds delivered to the issuer for payment of the exercise price of options under the issuer's incentive compensation plan and the related tax withholding.
Weighted average price, as these shares were sold in multiple transactions at prices ranging from $97.74 to $97.89 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, additional information regarding the number of shares sold at each separate price within the range set forth in this footnote.